Cargando…

Dendrimer-2PMPA selectively blocks upregulated microglial GCPII activity and improves cognition in a mouse model of multiple sclerosis

Cognitive impairment is a common aspect of multiple sclerosis (MS) for which there are no treatments. Reduced brain N-acetylaspartylglutamate (NAAG) levels are linked to impaired cognition in various neurological diseases, including MS. NAAG levels are regulated by glutamate carboxypeptidase II (GCP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hollinger, Kristen R., Sharma, Anjali, Tallon, Carolyn, Lovell, Lyndah, Thomas, Ajit G., Zhu, Xiaolei, Wiseman, Robyn, Wu, Ying, Kambhampati, Siva P., Liaw, Kevin, Sharma, Rishi, Rojas, Camilo, Rais, Rana, Kannan, Sujatha, Kannan, Rangaramanujam M., Slusher, Barbara S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671953/ https://www.ncbi.nlm.nih.gov/pubmed/34976589 http://dx.doi.org/10.7150/ntno.63158

Ejemplares similares

Dendrimer-conjugated glutaminase inhibitor selectively targets microglial glutaminase in a mouse model of Rett syndrome
por: Khoury, Elizabeth Smith, et al.
Publicado: (2020)

Targeting Mitochondrial Dysfunction and Oxidative Stress in Activated Microglia using Dendrimer-Based Therapeutics
por: Sharma, Anjali, et al.
Publicado: (2018)

Scalable synthesis and validation of PAMAM dendrimer‐N‐acetyl cysteine conjugate for potential translation
por: Sharma, Rishi, et al.
Publicado: (2018)

Dense hydroxyl polyethylene glycol dendrimer targets activated glia in multiple CNS disorders
por: Sharma, Anjali, et al.
Publicado: (2020)

Dendrimer-Conjugated Glutamate Carboxypeptidase II Inhibitor Restores Microglial Changes in a Rabbit Model of Cerebral Palsy
por: Sah, Nirnath, et al.
Publicado: (2023)

Microglial migration and interactions with dendrimer nanoparticles are altered in the presence of neuroinflammation
por: Zhang, Fan, et al.
Publicado: (2016)

Dendrimer-Conjugated nSMase2 Inhibitor Reduces Tau Propagation in Mice
por: Tallon, Carolyn, et al.
Publicado: (2022)

A role for the locus coeruleus in the analgesic efficacy of N-acetylaspartylglutamate peptidase (GCPII) inhibitors ZJ43 and 2-PMPA
por: Nonaka, Takahiro, et al.
Publicado: (2017)

Targeted systemic dendrimer delivery of CSF‐1R inhibitor to tumor‐associated macrophages improves outcomes in orthotopic glioblastoma
por: Liaw, Kevin, et al.
Publicado: (2020)

Preferential and Increased Uptake of Hydroxyl-Terminated PAMAM Dendrimers by Activated Microglia in Rabbit Brain Mixed Glial Culture
por: Alnasser, Yossef, et al.
Publicado: (2018)

Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration
por: Liaw, Kevin, et al.
Publicado: (2020)

Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome
por: Nance, Elizabeth, et al.
Publicado: (2017)

Correction to: Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome
por: Nance, Elizabeth, et al.
Publicado: (2018)

Microglial-Targeted nSMase2 Inhibitor Fails to Reduce Tau Propagation in PS19 Mice
por: Huang, Meixiang, et al.
Publicado: (2023)

Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration
por: Rais, Rana, et al.
Publicado: (2015)

Systemic administration of dendrimer N‐acetyl cysteine improves outcomes and survival following cardiac arrest
por: Modi, Hiren R., et al.
Publicado: (2021)

Galactosylated hydroxyl‐polyamidoamine dendrimer targets hepatocytes and improves therapeutic outcomes in a severe model of acetaminophen poisoning‐induced liver failure
por: Porterfield, Joshua E., et al.
Publicado: (2023)

Dendrimer Brain Uptake and Targeted Therapy for Brain Injury in a Large Animal Model of Hypothermic Circulatory Arrest
por: Mishra, Manoj K., et al.
Publicado: (2014)

Dendrimer-Based N-Acetyl Cysteine Maternal Therapy Ameliorates Placental Inflammation via Maintenance of M1/M2 Macrophage Recruitment
por: Liu, Yang, et al.
Publicado: (2022)

Systemic dendrimer-drug nanomedicines for long-term treatment of mild-moderate cerebral palsy in a rabbit model
por: Zhang, Zhi, et al.
Publicado: (2020)

Nanotechnology Approaches for Ocular Drug Delivery
por: Xu, Qingguo, et al.
Publicado: (2013)

Systemic Dendrimer-Peptide Therapies for Wet Age-Related Macular Degeneration
por: Wu, Tony, et al.
Publicado: (2023)

Targeted Brain Delivery of Dendrimer-4-Phenylbutyrate Ameliorates Neurological Deficits in a Long-Term ABCD1-Deficient Mouse Model of X-Linked Adrenoleukodystrophy
por: Nemeth, Christina L., et al.
Publicado: (2022)

Mouse glutamate carboxypeptidase II (GCPII) has a similar enzyme activity and inhibition profile but a different tissue distribution to human GCPII
por: Knedlík, Tomáš, et al.
Publicado: (2017)

Chronic GCPII (glutamate‐carboxypeptidase‐II) inhibition reduces pT217Tau levels in the entorhinal and dorsolateral prefrontal cortices of aged macaques
por: Bathla, Shveta, et al.
Publicado: (2023)

Maternal dendrimer-based therapy for inflammation-induced preterm birth and perinatal brain injury
por: Lei, Jun, et al.
Publicado: (2017)

Neuroprotective effects of a dendrimer-based glutamate carboxypeptidase inhibitor on superoxide dismutase transgenic mice after neonatal hypoxic-ischemic brain injury
por: Cabeza, O. Arteaga, et al.
Publicado: (2020)

The distribution of the anti-HIV drug, tenofovir (PMPA), into the brain, CSF and choroid plexuses
por: Anthonypillai, Christy, et al.
Publicado: (2006)

Nanomedicine in cerebral palsy
por: Balakrishnan, Bindu, et al.
Publicado: (2013)

Dendrimers Target the Ischemic Lesion in Rodent and Primate Models of Nonarteritic Anterior Ischemic Optic Neuropathy
por: Guo, Yan, et al.
Publicado: (2016)

Neutral sphingomyelinase 2 inhibition attenuates extracellular vesicle release and improves neurobehavioral deficits in murine HIV
por: Zhu, Xiaolei, et al.
Publicado: (2022)

Microglial Metabolism After Pediatric Traumatic Brain Injury – Overlooked Bystanders or Active Participants?
por: Shi, Aria C., et al.
Publicado: (2021)

Deletion of glutamate carboxypeptidase II (GCPII), but not GCPIII, provided long‐term benefits in mice with traumatic brain injury
por: Ji, Tongjie, et al.
Publicado: (2023)

Engineering clinical translation‐Introduction to Special Issue Dedicated to 2017 Bioengineering and Translational Medicine Conference
por: Kannan, Rangaramanujam M., et al.
Publicado: (2018)

Engineering clinical translation‐Introduction to Special Issue Dedicated to 2017 Bioengineering and Translational Medicine Conference
por: Kannan, Rangaramanujam M., et al.
Publicado: (2018)

Use of Polyamidoamine Dendrimers in Brain Diseases
por: Florendo, Maria, et al.
Publicado: (2018)

Analysis of Polymorphic Membrane Protein Expression in Cultured Cells Identifies PmpA and PmpH of Chlamydia psittaci as Candidate Factors in Pathogenesis and Immunity to Infection
por: Van Lent, Sarah, et al.
Publicado: (2016)

Nanoparticle-based targeting of microglia improves the neural regeneration enhancing effects of immunosuppression in the zebrafish retina
por: Emmerich, Kevin, et al.
Publicado: (2023)

Dendrimer-Based Selective Proteostasis-Inhibition Strategy to Control NSCLC Growth and Progression
por: Walworth, Kyla, et al.
Publicado: (2016)

Functional Characterization of PknI-Rv2159c Interaction in Redox Homeostasis of Mycobacterium tuberculosis
por: Venkatesan, Arunkumar, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_10pgilmvj1o2gvefh8f8o44k14